Bridgeway Capital Management, LLC Biom X Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.14 - $4.52 $1,288 - $41,583	-9,200 Reduced 15.67%	49,500 $9,000
Q1 2022 May 16, 2022	SELL	$12.1 - $20.6 $484,000 - $824,000	-40,000 Reduced 40.53%	58,700 $113,000
Q4 2021 Feb 14, 2022	SELL	$14.4 - $30.4 $1.47 Million - $3.1 Million	-102,000 Reduced 50.82%	98,700 $158,000
Q3 2021 Nov 15, 2021	BUY	$30.6 - $58.1 $2.96 Million - $5.62 Million	96,700 Added 92.98%	200,700 $614,000
Q2 2021 Aug 16, 2021	SELL	$52.6 - $72.5 $999,400 - $1.38 Million	-19,000 Reduced 15.45%	104,000 $568,000
Q1 2021 May 17, 2021	BUY	$63.1 - $86.4 $7.76 Million - $10.6 Million	123,000 New	123,000 $876,000

301K

Ticker PHGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,982,300
Market Cap $19.2M
Description
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.